Dallas Webb says his firm focuses on long-term investing in the biotech sector. Mr. Webb says that right now in the space there is a lot of focus on the immune-oncology space, which is harnessing the body’s own immune response to help fight cancers. He is seeing really interesting clinical data on that front. Mr. Webb says the other big topic is drug pricing control from the government. He aims to invest in companies that are developing truly innovative science and truly innovative drugs, and highlights several companies he finds interesting.
Full interview available here.
Interview Highlights: Marc Saint John Webb of Quaero Capital SA on Investing Strategies
December 23, 2016
Interview Highlights: Andrew Boord of Fenimore Asset Management on Investing Strategies
August 18, 2016
Interview Highlights: Chris Lagan and Todd Solomon of Congress Asset Management Company on Investing Strategies
August 31, 2016
Interview Highlights: Ken Ichikawa Siazon of Southeastern Asset Management on Investing Strategies
September 19, 2016
Interview Highlights: William H. Mann III of Motley Fool Asset Management on Investing Strategies
September 29, 2016
